Featured
Featured posts
June 1, 2018
Trial Results For Schizophrenia Drug From Minerva Neurosciences Inc (NASDAQ: NERV) Boost The Company’s Shares Minerva Neurosciences Inc (NASDAQ: NERV) has every reason to celebrate. The clinical-stage […]
May 30, 2018
The FDA Approves The Subcutaneous (SC) Formulation Of Actemra From Roche Holdings (OTCMKTS: RHHBY) The US Food and Drug Administration (FDA) has endorsed the subcutaneous (SC) formulation […]
May 19, 2018
Alpine Immune Sciences Inc (NASDAQ:ALPN) Is Focusing On INDs For ALPN-101 To Cure Autoimmune/Inflammatory Conditions Alpine Immune Sciences Inc (NASDAQ:ALPN) recently announced its corporate update and financial […]
May 15, 2018
Lonestar Resources US Inc (NASDAQ:LONE) Reports 48% Increase In Net Oil And Gas Production In Q1 Lonestar Resources US Inc (NASDAQ:LONE) recently announced its financial and […]